The DOI matches its Crossref record, with a small difference in title or year; 202 of the 203 references it cites were found in a registry or an index.
Recent Progress in Understanding the Pathophysiology of Post-Traumatic Stress Disorder: Implications for Targeted Pharmacological Treatment
Open accessAbstract
Post-traumatic stress disorder (PTSD) is a common and chronic anxiety disorder that can result after exposure to a traumatic event. Though our understanding of the aetiology of PTSD is incomplete, several neurobiological systems have been implicated in the pathophysiology and vulnerability towards developing PTSD after trauma exposure. We aimed to provide a concise review of benchmark findings in important neurobiological systems related to the aetiology and maintenance of PTSD symptomology. Specifically, we discuss functional aetiologies in the noradrenergic, serotonergic, endogenous cannabinoid and opioid systems as well as the hypothalamic-pituitary adrenal (HPA) axis. This article provides a succinct framework to appreciate the current understanding of neurobiological mechanisms related to the pathophysiology of PTSD and how these findings may impact the development of future, targeted pharmacological treatments for this debilitating disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other neuropeptides/neurotrophic factors, such as neuropeptide Y (95), dynorphin (96), and oxytocin as well as brain-derived neurotrophic factor (BDNF), are also involved in the HPA axis and in the orchestration of the response to stress.”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [96]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pietrzak, R. H., Gallezot, J., Ding, Y., Henry, S. E., Potenza, M. N., Southwick, S. M., Krystal, J. H., Carson, R. E., & Neumeister, A. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.399 · Cited by 127
Self-citationRetractedPosttraumatic Stress Disorder in the National Comorbidity Survey
Kessler, R. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240066012 · Cited by 10,379
da Luz, A. C. D. D. S., Dias, G. P., Bevilaqua, M. C. D. N., Cocks, G. D., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 4,015
Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress
Tsigos, C., & Chrousos, G. P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00429-4 · Cited by 2,822
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689
Traumatic Events and Posttraumatic Stress Disorder in an Urban Population of Young Adults
Breslau, N. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810270028003 · Cited by 2,544
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 1×
“The first CB1 receptor was discovered relatively recently by Allyn Howlett’s laboratory in 1988 [116, 117], and since then there has been substantial attention devoted to this neuromodulatory system.”
BackgroundTrauma and Posttraumatic Stress Disorder in the Community: The 1996 Detroit Area Survey of Trauma
Breslau, N., Kessler, R. C., Chilcoat, H. D., Schultz, L. R., Davis, G. C., & Andreski, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.7.626 · Cited by 2,407
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
STRESS AND HIPPOCAMPAL PLASTICITY
McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087
Heim, C. (2000) · JAMA · doi:10.1001/jama.284.5.592 · Cited by 1,968
Resnick, H. S., Kilpatrick, D. G., Dansky, B. S., Saunders, B. E., & al, E. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.61.6.984 · Cited by 1,868
Resnick, H. S., Kilpatrick, D. G., Dansky, B. S., Saunders, B. E., & Best, C. L. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.61.6.984 · Cited by 1,868
Neurons in medial prefrontal cortex signal memory for fear extinction
Milad, M. R., & Quirk, G. J. (2002) · Nature · doi:10.1038/nature01138 · Cited by 1,836 · cited 1×
“Early studies using the a2-selective antagonist yohimbine, which acts on both pre- and post-synaptic receptors and increases noradrenaline activity, helped form a model suggesting that increased noradrenaline activity leads to impaired medial prefrontal cortex functioning [27, 37] and fear extinction [38, 39], explain…”
BackgroundThe endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders
Heim, C., Ehlert, U., & Hellhammer, D. H. (2000) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00035-9 · Cited by 1,688
Sex differences in HPA axis responses to stress: a review
Kudielka, B. M., & Kirschbaum, C. (2005) · Biological Psychology · doi:10.1016/j.biopsycho.2004.11.009 · Cited by 1,624
Fear conditioning induces associative long-term potentiation in the amygdala
Rogan, M. T., Stäubli, U. V., & LeDoux, J. E. (1997) · Nature · doi:10.1038/37601 · Cited by 1,310
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Amygdala, medial prefrontal cortex, and hippocampal function in PTSD
SHIN, L. M., RAUCH, S. L., & PITMAN, R. K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.007 · Cited by 1,203
Raison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
Neurotransmitter Transporters: Recent Progress
Amara, S., & Kuhar, M. J. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.000445 · Cited by 1,088
Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052
Post-traumatic stress disorder in the community: an epidemiological study
Davidson, J. R. T., Hughes, D., Blazer, D. G., & George, L. K. (1991) · Psychological Medicine · doi:10.1017/s0033291700022352 · Cited by 969
Pilot study of secondary prevention of posttraumatic stress disorder with propranolol
Pitman, R. K., Sanders, K. M., Zusman, R. M., Healy, A. R., Cheema, F., Lasko, N. B., Cahill, L., & Orr, S. P. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01279-3 · Cited by 964
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948
Plasma membrane monoamine transporters: structure, regulation and function
Torres, G. E., Gainetdinov, R. R., & Caron, M. G. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1008 · Cited by 936
What Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 865
Bale, T. L., Contarino, A., Smith, G. W., Chan, R. K. W., Gold, L. H., Sawchenko, P. E., Koob, G. F., Vale, W. W., & Lee, K. (2000) · Nature Genetics · doi:10.1038/74263 · Cited by 850
Serotonin receptor 1A knockout: An animal model of anxiety-related disorder
Ramboz, S., Oosting, R. S., Amara, D. A., Kung, H. F., Blier, P., Mendelsohn, M. M., Mann, J. J., Brunner, D., & Hen, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14476 · Cited by 831
The effects of cannabinoids on the brain
Ameri, A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00087-2 · Cited by 825
Molecular biology of 5-HT receptors
Hannon, J., & Hoyer, D. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.03.020 · Cited by 815
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor
Ressler, K. J., Mercer, K. B., Bradley, B., Jovanovic, T., Mahan, A., Kerley, K., Norrholm, S. D., Kilaru, V., Smith, A. K., Myers, A. J., et al. (2011) · Nature · doi:10.1038/nature09856 · Cited by 800
CLASSIFICATION OF OPIOID RECEPTORS
PATERSON, S. J., Robson, L. E., & Kosterlitz, H. W. (1983) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071787 · Cited by 793
International Union of Pharmacology. XII. Classification of opioid receptors
Bn, D., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P. B., Portoghese, P. S., & Hamon, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06958-3 · Cited by 732
Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.5.624 · Cited by 721
Zobel, A. W., Nickel, T., Künzel, H. E., Ackl, N., Sonntag, A., Ising, M., & Holsboer, F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00016-9 · Cited by 705
Serotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors
Pazos, Á., Probst, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90326-5 · Cited by 684
Morón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681
Serotoninergic regulation of emotional and behavioural control processes
Cools, R., Roberts, A. C., & Robbins, T. W. (2008) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2007.10.011 · Cited by 656
Friedman, M. J., Resick, P. A., Bryant, R. A., & Brewin, C. R. (2011) · Depression and Anxiety · doi:10.1002/da.20767 · Cited by 629
Coste, S. C., Kesterson, R. A., Heldwein, K. A., Stevens, S. L., Heard, A. D., Hollis, J. H., Murray, S., Hill, J. K., Pantely, G. A., Hohimer, A. R., et al. (2000) · Nature Genetics · doi:10.1038/74255 · Cited by 588
Wong, M., Kling, M. A., Munson, P. J., Listwak, S. J., Licinio, J., Prolo, P., Karp, B., McCutcheon, I. E., Geracioti, T. D., DeBellis, M. D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.325 · Cited by 581
Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder
Southwick, S. M., Bremner, J. D., Rasmusson, A., Morgan, C. A., Arnsten, A., & Charney, D. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00219-x · Cited by 573
Role of brain norepinephrine in the behavioral response to stress
Morilak, D. A., Barrera, G., Echevarria, D. J., Garcia, A. S., Hernandez, A., Ma, S., & Petre, C. O. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.007 · Cited by 570
Animal models of anxiety and depression: how are females different?
Palanza, P. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00010-0 · Cited by 559
Neuroendocrinology and pathophysiology of the stress system
STRATAKIS, C. A., & CHROUSOS, G. P. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44666.x · Cited by 533
Baker, D. G., West, S. A., Nicholson, W. E., Ekhator, N. N., Kasckow, J. W., Hill, K. K., Bruce, A. B., Orth, D. N., & Geracioti, T. D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.585 · Cited by 531
Involvement of CB1 cannabinoid receptors in emotional behaviour
Martín, M., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0946-5 · Cited by 525
Pharmacotherapy for post traumatic stress disorder (PTSD)
Stein, D. J., Ipser, J. C., Seedat, S., Sager, C., & Amos, T. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002795.pub2 · Cited by 519
Molecular mechanisms underlying emotional learning and memory in the lateral amygdala
Rodrigues, S. M., Schafe, G. E., & LeDoux, J. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.014 · Cited by 491
Endocannabinoid system and stress and anxiety responses
VIVEROS, M., MARCO, E., & FILE, S. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.029 · Cited by 485
Patel, S., Roelke, C. T., Rademacher, D. J., Cullinan, W. E., & Hillard, C. J. (2004) · Endocrinology · doi:10.1210/en.2004-0638 · Cited by 475
Dynorphin, stress, and depression
Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465
CSF Norepinephrine Concentrations in Posttraumatic Stress Disorder
Geracioti, T. D., Baker, D. G., Ekhator, N. N., West, S. A., Hill, K. K., Bruce, A. B., Schmidt, D., Rounds-Kugler, B., Yehuda, R., Keck, P. E., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1227 · Cited by 462
How the Neurocircuitry and Genetics of Fear Inhibition May Inform Our Understanding of PTSD
Jovanović, T., & Ressler, K. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09071074 · Cited by 457
Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression
Klimek, V., Stockmeier, C. A., Overholser, J. C., Meltzer, H. Y., Kalka, S., Dilley, G. E., & Ordway, G. A. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08451.1997 · Cited by 445
Charney, D. S., & Manji, H. K. (2004) · Science s STKE · doi:10.1126/stke.2252004re5 · Cited by 437
Morphine use after combat injury in Iraq and post-traumatic stress disorder
Holbrook, T. L., Galarneau, M. R., Dye, J. L., Quinn, K., & Dougherty, A. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0903326 · Cited by 429
Tanaka, M., Yoshida, M., Emoto, H., & Ishii, H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00569-0 · Cited by 382
Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear
Chhatwal, J. P., Davis, M., Maguschak, K. A., & Ressler, K. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300655 · Cited by 376
Wellman, C. L., Izquierdo, A., Garrett, J. E., Martin, K. P., Carroll, J., Millstein, R., Lesch, K.-P., Murphy, D. L., & Holmes, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4595-06.2007 · Cited by 366
Hill, M. N., Patel, S., Carrier, E. J., Rademacher, D. J., Ormerod, B. K., Hillard, C. J., & Gorzalka, B. B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300601 · Cited by 363
Gender differences in susceptibility to posttraumatic stress disorder
Stein, M. B., Walker, J. R., & Forde, D. R. (2000) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(99)00098-4 · Cited by 356
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety
Haller, J., Bakos, N., Szirmay, M., Ledent, C., & Freund, T. F. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02192.x · Cited by 354
Endogenous cannabinoid signaling is essential for stress adaptation
Hill, M. N., McLaughlin, R. J., Bingham, B., Shrestha, L., Lee, T. T. Y., Gray, J. M., Hillard, C. J., Gorzalka, B. B., & Viau, V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914661107 · Cited by 349
Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review
Berger, W., Mendlowicz, M. V., Marques-Portella, C., Kinrys, G., Fontenelle, L. F., Marmar, C. R., & Figueira, I. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.12.004 · Cited by 347
Serotonin receptors: from protein to physiological function and behavior
Sari, Y. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.08.008 · Cited by 347
Hill, M. N., & Tasker, J. G. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.030 · Cited by 346
Sexual and Physical Abuse History in Gastroenterology Practice
Leserman, J., Drossman, D. A., Li, Z., Toomey, T. C., Nachman, G., & Glogau, L. (1996) · Psychosomatic Medicine · doi:10.1097/00006842-199601000-00002 · Cited by 341
Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor
Wong, E. H. F., Sonders, M. S., Amara, S. G., Tinholt, P. M., Piercey, M. F., Hoffmann, W. P., Hyslop, D. K., Franklin, S. R., Porsolt, R. D., Bonsignori, A., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00291-7 · Cited by 334
Current perspectives of the roles of the central norepinephrine system in anxiety and depression
Goddard, A. W., Ball, S. G., Martinez, J. M., Robinson, M. J., Yang, C. R., Russell, J. M., & Shekhar, A. (2009) · Depression and Anxiety · doi:10.1002/da.20642 · Cited by 332
Hill, M. N., Miller, G. E., Carrier, E. J., Gorzalka, B. B., & Hillard, C. J. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.03.013 · Cited by 328
Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder
Strawn, J. R., & Geracioti, T. D. (2007) · Depression and Anxiety · doi:10.1002/da.20292 · Cited by 325
Noradrenergic and Serotonergic Function in Posttraumatic Stress Disorder
Southwick, S. M. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200083012 · Cited by 319
Chamberlain, S. R., Hampshire, A., Müller, U., Rubia, K., del Campo, N., Craig, K. J., Regenthal, R., Suckling, J., Roiser, J. P., Grant, J. E., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.014 · Cited by 313
Hill, M. N., McLaughlin, R. J., Morrish, A. C., Viau, V., Floresco, S. B., Hillard, C. J., & Gorzalka, B. B. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.114 · Cited by 304
Charney, D. S., Woods, S. W., Goodman, W. K., & Heninger, G. R. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.8.1030 · Cited by 301
Bremner, J. D. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830150070011 · Cited by 299
Bale, T. L., Picetti, R., Contarino, A., Koob, G. F., Vale, W., & Lee, K. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00193.2002 · Cited by 293
Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary Report
Hill, M., Miller, G., Ho, W.-S., Gorzalka, B., & Hillard, C. (2008) · Pharmacopsychiatry · doi:10.1055/s-2007-993211 · Cited by 292
Weiss, N. H., Tull, M. T., Viana, A. G., Anestis, M. D., & Gratz, K. L. (2012) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2012.01.007 · Cited by 290
Trauma: prevalence, impairment, service use, and cost.
Solomon, S. D., & Davidson, J. R. T. (1997) · PubMed · Cited by 289
Krystal, J. H., Webb, E., Cooney, N. L., Kranzler, H. R., Southwick, S. W., Heninger, G. R., & Charney, D. S. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.1.83 · Cited by 268
Neuropharmacology of Serotonin
(1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90276-8 · Cited by 267
Gender differences in trauma and posttraumatic stress disorder.
Breslau, N. (2002) · PubMed · Cited by 264
Breslau, N., & Anthony, J. C. (2007) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.116.3.607 · Cited by 264
Krystal, J. H., & Neumeister, A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.044 · Cited by 264
Self-citationXie, P., Kranzler, H. R., Poling, J., Stein, M. B., Anton, R. F., Brady, K., Weiss, R. D., Farrer, L., & Gelernter, J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.153 · Cited by 264
Binneman, B., Feltner, D., Kolluri, S., Shi, Y., Qiu, R., & Stiger, T. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071199 · Cited by 254 · cited 1×
“CRF-1 receptor antagonism is a treatment modality that has been explored for the treatment of MDD [166], while an initial open-label study suggested promising efficacy data, these results were not confirmed in follow-up placebo-controlled trials [167].”
ResultCukor, J., Spitalnick, J. S., Difede, J., Rizzo, A., & ROTHBAUM, B. O. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.09.001 · Cited by 251
Stein, M. B., Kerridge, C., Dimsdale, J. E., & Hoyt, D. B. (2007) · Journal of Traumatic Stress · doi:10.1002/jts.20270 · Cited by 249
Hill, M. N., Carrier, E. J., McLaughlin, R. J., Morrish, A. C., Meier, S. E., Hillard, C. J., & Gorzalka, B. B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05567.x · Cited by 246
Simonin, F., Gavériaux‐Ruff, C., Befort, K., Matthes, H. W. D., Lannes, B., Micheletti, G., Mattéi, M., Charron, G., Bloch, B., & Kieffer, B. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7006 · Cited by 245
The role of serotonin receptor subtypes in treating depression: a review of animal studies
Carr, G. V., & Lucki, I. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2097-z · Cited by 244
Reich, C. G., Taylor, M. E., & McCarthy, M. M. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.05.013 · Cited by 244
Friedman, M. J., Marmar, C. R., Baker, D. G., Sikes, C. R., & Farfel, G. M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0508 · Cited by 243
Haller, J., Varga, B., Ledent, C., & Freund, T. F. (2004) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000135704.56422.40 · Cited by 241 · cited 1×
“cological disruption of CB1 receptor signalling, which is required for normal fear extinction [121–123], results in an anxious PTSD phenotype [126, 127], and brain CB1 receptor signalling controls extinction of aversive memo-”
BackgroundThe Role of the Dorsal Hippocampal Serotonergic and Cholinergic Systems in the Modulation of Anxiety
File, S. E., Kenny, P. J., & Cheeta, S. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00198-2 · Cited by 239
Rademacher, D. J., Meier, S. E., Shi, L., Vanessa Ho, W.-S., Jarrahian, A., & Hillard, C. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.012 · Cited by 233
Treatment of Posttraumatic Stress Disorder With Venlafaxine Extended Release
Davidson, J. R. T., Baldwin, D. S., Stein, D. J., Kuper, E., Benattia, I., Ahmed, S., Pedersen, R., & Musgnung, J. J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1158 · Cited by 230
Dębiec, J., Bush, D. E. A., & LeDoux, J. E. (2011) · Depression and Anxiety · doi:10.1002/da.20803 · Cited by 227
Knoll, A. T., Meloni, E. G., Thomas, J. B., Carroll, F. I., & Carlezon, W. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127415 · Cited by 227
Pietrzak, R. H., Goldstein, R. B., Southwick, S. M., & Grant, B. F. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31820d92e7 · Cited by 217
Imaging of opioid receptors in the central nervous system
Henriksen, G., & Willoch, F. (2008) · Brain · doi:10.1093/brain/awm255 · Cited by 214
Gorzalka, B. B., Hill, M. N., & Hillard, C. J. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.004 · Cited by 211
Bryant, R. A., Creamer, M. C., O'Donnell, M. L., Silove, D. M., & McFARLANE, A. C. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.032 · Cited by 210
Bruchas, M. R., Land, B. B., Lemos, J. C., & Chavkin, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008528 · Cited by 209
Serotonin type-1A receptor imaging in depression
Drevets, W. C., Frank, E., Price, J. C., Kupfer, D. J., Greer, P. J., & Mathis, C. A. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00119-0 · Cited by 206
Cohen, H., Kaplan, Z., Koresh, O., Matar, M. A., Geva, A. B., & Zohar, J. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.11.011 · Cited by 204
Ditlevsen, D. N., & Elklit, A. (2010) · Annals of General Psychiatry · doi:10.1186/1744-859x-9-32 · Cited by 204
Tsigos, C., & Chrousos, G. P. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30078-1 · Cited by 203
Gender differences in depression and PTSD symptoms following combat exposure
Luxton, D. D., Skopp, N. A., & Maguen, S. (2010) · Depression and Anxiety · doi:10.1002/da.20730 · Cited by 198
Pharmacological treatment of PTSD – Established and new approaches
Steckler, T., & Risbrough, V. B. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.012 · Cited by 188
Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system.
Azmitia, E. C., & Whitaker‐Azmitia, P. M. (1991) · PubMed · Cited by 184
Serotonin neurons, neuroplasticity, and homeostasis of neural tissue
Azmitia, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00022-6 · Cited by 184
Whitaker‐Azmitia, P. M., Clarke, C., & Azmitia, E. C. (1993) · Synapse · doi:10.1002/syn.890140303 · Cited by 181
Varvel, S. A., Wise, L. E., Niyuhire, F., Cravatt, B. F., & Lichtman, A. H. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301224 · Cited by 179
Glutamate Receptors in Extinction and Extinction-Based Therapies for Psychiatric Illness
Myers, K. M., Carlezon, W. A., & Davis, M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.88 · Cited by 177
Chronic Pain in Women Survivors of Intimate Partner Violence
Wuest, J., Merritt-Gray, M., Ford-Gilboe, M., Lent, B., Varcoe, C., & Campbell, J. C. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2008.06.009 · Cited by 175
Hoge, E. A., Worthington, J. J., Nagurney, J. T., Chang, Y., Kay, E. B., Feterowski, C. M., Katzman, A. R., Goetz, J. M., Rosasco, M. L., Lasko, N. B., et al. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00227.x · Cited by 174 · cited 1×
“Clinical evidence has shown a similar trend regarding propranolol as a PTSD prophylactic [44, 45] with several contrary findings [46, 47].”
ResultMedical Comorbidity of Full and Partial Posttraumatic Stress Disorder in US Adults
Pietrzak, R. H., Goldstein, R. B., Southwick, S. M., & Grant, B. F. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3182303775 · Cited by 174
Noradrenergic Mechanisms in the Pathophysiology of Post-Traumatic Stress Disorder
O'Donnell, T., Hegadoren, K., & Coupland, N. (2004) · Neuropsychobiology · doi:10.1159/000080952 · Cited by 166
Gender differences in PTSD symptoms: An exploration of peritraumatic mechanisms
Irish, L. A., Fischer, B., Fallon, W. F., Spoonster, E., Sledjeski, E. M., & Delahanty, D. L. (2010) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2010.09.004 · Cited by 165
Haddjeri, N., De Montigny, C., & Blier, P. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700968 · Cited by 164
Wrong, M. (2000) · Medical Entomology and Zoology · Cited by 159
Davidson, J., Rothbaum, B. O., Tucker, P., Asnis, G., Benattia, I., & Musgnung, J. J. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000222514.71390.c1 · Cited by 157
Dell’Osso, L., Carmassi, C., Massimetti, G., Daneluzzo, E., Tommaso, S. D., & Rossi, A. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.11.023 · Cited by 155
Interactions between Kappa Opioid Agonists and Cocaine: Preclinical Studies
Mello, N. K., & Negus, S. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06678.x · Cited by 145
Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity
Holsboer, F. (1989) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00449812 · Cited by 144
Suárez, J., Llorente, R., Romero‐Zerbo, S., Mateos, B., Bermúdez‐Silva, F. J., de Fonseca, F. R., & Viveros, M. (2008) · Hippocampus · doi:10.1002/hipo.20537 · Cited by 142
Whitaker‐Azmitia, P. M., & Azmitia, E. C. (1989) · Brain Research · doi:10.1016/0006-8993(89)90972-4 · Cited by 141
Limited efficacy of propranolol on the reconsolidation of fear memories
Muravieva, E. V., & Alberini, C. M. (2010) · Learning & Memory · doi:10.1101/lm.1794710 · Cited by 135
Krebs-Kraft, D. L., Hill, M. N., Hillard, C. J., & McCarthy, M. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005003107 · Cited by 130
Sex differences and the HPA axis: implications for psychiatric disease.
Young, E. A. (1998) · PubMed · Cited by 126
Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in Wistar Kyoto Rats
Carr, G. V., Bangasser, D. A., Bethea, T. T., Young, M., Valentino, R. J., & Lucki, I. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.183 · Cited by 124
The Endocannabinoid System and Extinction Learning
Lutz, B. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8004-x · Cited by 124
Petrakis, I. L., Ralevski, E., Desai, N., Trevisan, L. A., Gueorguieva, R. V., Rounsaville, B. J., & Krystal, J. H. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.283 · Cited by 122
Susskind, O., Ruzek, J., & Friedman, M. (2012) · Journal of rehabilitation research and development · doi:10.1682/jrrd.2011.12.0241 · Cited by 119
Mathieu-Kia, A.-M., Fan, L.-Q., Kreek, M. J., Simon, E. J., & Hiller, J. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03302-3 · Cited by 118
Interpersonal friction and PTSD in female victims of sexual and nonsexual assault
Zoellner, L. A., Foa, E. B., & Brigidi, B. D. (1999) · Journal of Traumatic Stress · doi:10.1023/a:1024777303848 · Cited by 117
Roozendaal, B., Schelling, G., & McGaugh, J. L. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1336-08.2008 · Cited by 115
Murrough, J. W. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.91 · Cited by 113
Bowler, R. M., Han, H., Gocheva, V. V., Nakagawa, S., Alper, H., DiGrande, L., & Cone, J. E. (2010) · American Journal of Industrial Medicine · doi:10.1002/ajim.20876 · Cited by 112
Noradrenergic enhancement of amygdala responses to fear
Onur, O. A., Walter, H., Schlaepfer, T. E., Rehme, A. K., Schmidt, C., Keysers, C., Maier, W., & Hurlemann, R. (2009) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsn049 · Cited by 111
The Neuropharmacology of Serotonin
Whitaker‐Azmitia, P. M., & Peroutka, S. J. (1990) · Medical Entomology and Zoology · Cited by 108
Miner, L. H., Jedema, H. P., Moore, F. W., Blakely, R. D., Grace, A. A., & Sesack, S. R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4450-05.2006 · Cited by 107
Ordway, G. A., Stockmeier, C. A., Cason, G. W., & Klimek, V. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01710.1997 · Cited by 107
Marshall-Berenz, E. C., Vujanovic, A. A., & MacPherson, L. (2011) · Personality and Individual Differences · doi:10.1016/j.paid.2010.11.033 · Cited by 104
Benedek, D. M., Friedman, M. J., Zatzick, D., & Ursano, R. J. (2009) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.7.2.foc204 · Cited by 103
The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression (Supplementary Tables)
Ruf, B. M., & Bhagwagar, Z. (2009) · Current Drug Targets · doi:10.2174/138945009789735192 · Cited by 100
Sex-dependent alterations in response to maternal deprivation in rats
Viveros, M., Llorente, R., López‐Gallardo, M., Suárez, J., Bermúdez‐Silva, F. J., la Fuente, M. D., de Fonseca, F. R., & García‐Segura, L. M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.015 · Cited by 99
Stoddard, F. J., Sorrentino, E. A., Ceranoglu, T. A., Saxe, G., Murphy, J. M., Drake, J. E., Ronfeldt, H. M., White, G. W., Kagan, J., Snidman, N. C., et al. (2009) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e3181b48102 · Cited by 98
Atomoxetine and Adult Attention-Deficit/Hyperactivity Disorder: The Effects of Comorbidity
Spencer, T. J., Faraone, S. V., Michelson, D., Adler, L. A., Reimherr, F. W., Glatt, S. J., & Biederman, J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0312 · Cited by 94 · cited 1×
“Early clinical evidence suggests that atomoxetine, which has a high affinity for the NET, increases inhibitory response control [62] and reduces attention-deficit hyperactivity disorder (ADHD) symptoms with co-morbid anxiety [63] and PTSD [64] diagnoses.”
BackgroundTreatment of PTSD: An Assessment of the Evidence
(2007) · PsycEXTRA Dataset · doi:10.1037/e719512007-001 · Cited by 92
Hubbard, D. T., Nakashima, B. R., Lee, I., & Takahashi, L. K. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.001 · Cited by 89
Yohimbine — facilitated acoustic startle reflex in humans
Morgan, C. A., Southwick, S. M., Grillon, C., Davis, M., Krystal, J. H., & Charney, D. S. (1993) · Psychopharmacology · doi:10.1007/bf02251291 · Cited by 87
A High Risk Twin Study of Combat-Related PTSD Comorbidity
Koenen, K. C., Lyons, M. J., Goldberg, J. H., Simpson, J., Williams, W. M., Toomey, R., Eisen, S. A., True, W. R., Cloître, M., Wolfe, J., et al. (2003) · Twin Research · doi:10.1375/136905203765693870 · Cited by 85
Liprando, L. A., Miner, L. H., Blakely, R., Lewis, D. A., & Sesack, S. R. (2004) · Synapse · doi:10.1002/syn.20023 · Cited by 84
Pharmacologic treatment of acute and chronic stress following trauma: 2006.
Davidson, J. R. T. (2006) · PubMed · Cited by 82
Galovski, T. E., Mott, J. M., Young‐Xu, Y., & Resick, P. A. (2010) · Journal of Interpersonal Violence · doi:10.1177/0886260510365865 · Cited by 82
Rusnák, M., Kvetnan̆ský, R., Jeloková, J., & Palkovits, M. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02126-6 · Cited by 81
Spinelli, S., Chefer, S. I., Carson, R. E., Jagoda, E. M., Lang, L., Heilig, M. A., Barr, C. S., Suomi, S. J., Higley, J. D., & Stein, E. A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.030 · Cited by 78
Laminar distribution of the multiple opioid receptors in the human cerebral cortex
Hiller, J. M., & Fan, L.-Q. (1996) · Neurochemical Research · doi:10.1007/bf02532374 · Cited by 78
Cheok, F., Schrader, G. D., Banham, D., Marker, J., & Hordacre, A. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00481-2 · Cited by 77
Sauriyal, D. S., Jaggi, A. S., & Singh, N. (2011) · Neuropeptides · doi:10.1016/j.npep.2010.12.004 · Cited by 76
Serotonin 1B Receptor Imaging in Alcohol Dependence
Hu, J., Henry, S. E., Gallezot, J., Ropchan, J. R., Neumaier, J. F., Potenza, M. N., Sinha, R., Krystal, J. H., Huang, Y. H., Ding, Y., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.028 · Cited by 71
Self-citationAdamec, R. E., Fougere, J. D., & Risbrough, V. B. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990496 · Cited by 69
Nixon, R. D. V., Nehmy, T. J., Ellis, A. A., Ball, S.-A., Menne, A., & McKinnon, A. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.05.002 · Cited by 67
McDevitt, R. A., Hiroi, R., Mackenzie, S. M., Robin, N. C., Cohn, A., Kim, J. J., & Neumaier, J. F. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.029 · Cited by 60
The Role of the Glutamatergic System in Posttraumatic Stress Disorder
Nair, J., & Ajit, S. S. (2008) · CNS Spectrums · doi:10.1017/s1092852900016862 · Cited by 60
Barrett, E. L., Mills, K. L., & Teesson, M. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.02.005 · Cited by 58
Dynorphin and the kappa 1 ligand [3H]U69,593 binding in the human epileptogenic hippocampus
de Lanerolle, N. C., Williamson, A., Meredith, C., Kim, J. H., Tabuteau, H., Spencer, D. D., & Brines, M. L. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00044-2 · Cited by 57
Chappell, P. B., Leckman, J. F., Scahill, L. D., Hardin, M. T., Anderson, G. M., & Cohen, D. J. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90084-t · Cited by 56
Grös, D. F., Frueh, B. C., & Magruder, K. M. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2011.06.005 · Cited by 56
5-HT1B Receptor-Mediated Presynaptic Inhibition of GABA Release in the Suprachiasmatic Nucleus
Bramley, J. R., Sollars, P. J., Pickard, G. E., & Dudek, F. E. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00770.2004 · Cited by 55
Kobori, N., Hu, B., & Dash, P. K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.048 · Cited by 53
Frazer, A., & Hensler, J. G. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16902.x · Cited by 53
Gender Differences in Traumatic Event Exposure and Mental Health Among Veteran Primary Care Patients
Freedy, J. R., Magruder, K. M., Mainous, A. G., Frueh, B. C., Geesey, M. E., & Carnemolla, M. A. (2010) · Military Medicine · doi:10.7205/milmed-d-10-00123 · Cited by 51
Yan, Q., Zheng, S., Feng, M., & Yan, S. (2005) · Brain Research · doi:10.1016/j.brainres.2005.08.051 · Cited by 51
Zanoveli, J. M., de Carvalho, M. C., da Cunha, J. M., & Brandão, M. L. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.074 · Cited by 51
Broocks, A., Meyer, T., Opitz, M., Bartmann, U., Hillmer-Vogel, U., George, A., Pekrun, G., Wedekind, D., Rüther, E., & Bandelow, B. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00177-3 · Cited by 49
Schiff, M., Levit, S., & Cohen-Moreno, R. (2010) · Social Work in Health Care · doi:10.1080/00981381003745103 · Cited by 45
5HT1A and 5HT1B receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats
Solati, J., Salari, A., & Bakhtiari, A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.058 · Cited by 44
Serotonin transporter deficient mice are vulnerable to escape deficits following inescapable shocks
Muller, J. M., Morelli, E., Ansorge, M. S., & Gingrich, J. A. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00652.x · Cited by 43
Neurobiology of Tryptophan Depletion in Depression: Effects of m-Chlorophenylpiperazine (mCPP)
Price, L. H. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00084-5 · Cited by 43
Bonaventure, P., Langlois, X., & Leysen, J. E. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00680-6 · Cited by 40
Post-traumatic stress disorder: emerging concepts of pharmacotherapy
Baker, D. G., Nievergelt, C. M., & Risbrough, V. B. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210902972494 · Cited by 39
Tanaka, Y., Ishitobi, Y., Maruyama, Y., Kawano, A., Ando, T., Imanaga, J., Okamoto, S., Kanehisa, M., Higuma, H., Ninomiya, T., et al. (2012) · Neuroscience Research · doi:10.1016/j.neures.2012.01.006 · Cited by 37
Pardini, M., Krüeger, F., Koenigs, M. R., Raymont, V., Hodgkinson, C. A., Zoubak, S., Goldman, D. A., & Grafman, J. H. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.1 · Cited by 35
Comorbidity of PTSD and depression: linked or separate incidence
Neria, Y., & Bromet, E. J. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01012-x · Cited by 33
Gabriel, A., & Violato, C. (2011) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-011-0063-1 · Cited by 30
Pietrzak, R. H., Henry, S., Southwick, S. M., Krystal, J. H., & Neumeister, A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.60 · Cited by 30
Self-citationMcAllister-Williams, H., Massey, A. E., & Fairchild, G. F. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107078292 · Cited by 26
Yang, C.-H., Shi, H.-S., Zhu, W.-L., Wu, P., Sun, L.-L., Si, J.-J., Liu, M.-M., Zhang, Y., Suo, L., & Yang, J.-L. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.02.023 · Cited by 25
Pharmacotherapy for prevention of post-traumatic stress disorder
Ipser, J., Seedat, S., & Stein, D. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006239 · Cited by 23
Furay, A. R., Neumaier, J. F., Mullenix, A. T., Kaiyala, K. J., Sandygren, N. A., & Hoplight, B. J. (2010) · Alcohol · doi:10.1016/j.alcohol.2010.07.010 · Cited by 23
Dazzi, L., Seu, E., Cherchi, G., & Biggio, G. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02130-7 · Cited by 21
Tarsitani, L., Santis, V. D., Mistretta, M., Parmigiani, G., Zampetti, G., Roselli, V., Vitale, D., Tritapepe, L., Biondi, M., & Picardi, A. (2011) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2011.09.011 · Cited by 19
The Serotonin 1B Receptor: A New Target for Depression Therapeutics?
Murrough, J. W., & Neumeister, A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.020 · Cited by 16
Self-citation
Cited by
Sorted by citations
Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma
Jiang, S., Postovit, L., Cattaneo, A., Binder, E. B., & Aitchison, K. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00808 · Cited by 288
“Other neuropeptides/neurotrophic factors, such as neuropeptide Y (95), dynorphin (96), and oxytocin as well as brain-derived neurotrophic factor (BDNF), are also involved in the HPA axis and in the orchestration of the response to stress.”
BackgroundMayo, L. M., Asratian, A., Lindé, J., Holm, L., Nätt, D., Augier, G., Stensson, N., Vecchiarelli, H. A., Balsevich, G., Aukema, R. J., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0215-1 · Cited by 175
PTSD: from neurobiology to pharmacological treatments
Kelmendi, B., Adams, T., Yarnell, S. C., Southwick, S., Abdallah, C., & Krystal, J. (2016) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v7.31858 · Cited by 136
Bowers, M. E., & Ressler, K. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.008 · Cited by 155
Rabinak, C. A., Angstadt, M., Lyons, M., Mori, S., Milad, M. R., Liberzon, I., & Phan, K. L. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.09.009 · Cited by 148
Metadata
- Authors
- Bailey, C. R., Cordell, E., Sobin, S. M., & Neumeister, A.
- Affiliations
- Johns Hopkins University (US)
- NYU Langone Health (US)
- Corresponding author
- Neumeister, Alexander
- Venue
- CNS Drugs
- Published
- 2013-03
- Volume
- 27
- Issue
- 3
- Pages
- 221-232
- ISSN
- 1172-7047 (ISSN-L)
- 1179-1934
- PMC
- PMC3629370
- OpenAlex
- W2085725087
- Cited by
- 89
- References
- 203
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 4 · 2023: 8 · 2022: 4 · 2021: 10 · 2020: 9 · 2019: 9 · 2018: 7 · 2017: 7 · 2016: 8 · 2015: 7 · 2014: 7 · 2013: 2
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health (R21MH085627, R01MH096876, R21MH081103, R21MH096105)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- post-traumatic stress disorder, pathophysiology, noradrenergic system, serotonergic system, endocannabinoid system, opioid system, hypothalamic-pituitary-adrenal axis, trauma exposure
- MeSH terms
- Animals, Female, Humans, Hypothalamo-Hypophyseal System, Male, Pituitary-Adrenal System, Stress Disorders, Post-Traumatic, Drug Design, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review